Allos is a startup based in the United Kingdom. Brouky records 1 investor associated with the company.
Allos provides a causal AI platform to simulate and predict pharmaceutical development processes, improving formulation development, scale-up, tech transfer, and clinical trials with data-driven, simulation-led experiments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.